# Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations

> **NCT02066129** · PHASE3 · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 254 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone 44 mcg
- **DRUG:** Fluticasone 220 mcg

## Key facts

- **NCT ID:** NCT02066129
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2017-04-21
- **Final completion:** 2017-04-21
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2018-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02066129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02066129, "Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02066129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*